机构风向标 | 仟源医药(300254)2025年二季度已披露持仓机构仅3家

Core Viewpoint - QianYuan Pharmaceutical (300254.SZ) reported its semi-annual results for 2025, highlighting an increase in institutional investor holdings and the presence of public funds [1] Group 1: Institutional Investors - As of August 26, 2025, three institutional investors disclosed holdings in QianYuan Pharmaceutical A-shares, totaling 7.2738 million shares, which represents 2.93% of the company's total share capital [1] - The institutional investors include Shandong Sanzu Private Securities Investment Fund Management Co., Ltd. - Sanzu Sky No. 1 Private Securities Investment Fund, Shandong Sanzu Private Securities Investment Fund Management Co., Ltd. - Sanzu Sky No. 5 Private Securities Investment Fund, and MORGAN STANLEY & CO. INTERNATIONAL PLC [1] - Compared to the previous quarter, the total institutional holding percentage increased by 0.61 percentage points [1] Group 2: Public Funds - During this reporting period, one public fund was disclosed, which is the ICBC Aggregate Mixed A Fund, unchanged from the previous quarter [1]